Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

REYNOLD A PANETTIERI

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1104830629
CMS profile
95015
Location
NEW BRUNSWICK, NJ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$204,116.87

137 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 137 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

REYNOLD A PANETTIERI

NPI 1104830629 · CMS profile ID 95015

Allopathic & Osteopathic Physicians / Internal Medicine / Pulmonary Disease

NEW BRUNSWICK, NJ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 137 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1104830629?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
REYNOLD A PANETTIERI, NPI 1104830629, CMS profile ID 95015. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 137 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1104830629?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). REYNOLD A PANETTIERI, NPI 1104830629, CMS profile ID 95015. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 137 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1104830629?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
REYNOLD A PANETTIERI, NPI 1104830629, CMS profile ID 95015, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 137 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1104830629?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

137 matching records · $204,116.87 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 137 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 137.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $125.0007/07/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104387477 CMS
AstraZeneca Pharmaceuticals LP $250.0007/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104623296 CMS
AstraZeneca Pharmaceuticals LP $5,200.0007/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105766142 CMS
AstraZeneca Pharmaceuticals LP $1,300.0007/01/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104505360 CMS
AstraZeneca Pharmaceuticals LP $1,300.0007/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105884055 CMS
AstraZeneca Pharmaceuticals LP $2,500.0006/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105648290 CMS
AstraZeneca Pharmaceuticals LP $15.0906/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104358917 CMS
AstraZeneca Pharmaceuticals LP $613.4306/27/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104418399 CMS
AstraZeneca Pharmaceuticals LP $344.2406/27/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104659123 CMS
AstraZeneca Pharmaceuticals LP $173.1606/27/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104668935 CMS
AstraZeneca Pharmaceuticals LP $22.5206/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105299320 CMS
AstraZeneca Pharmaceuticals LP $113.4806/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105387442 CMS
AstraZeneca Pharmaceuticals LP $3,900.0006/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105606275 CMS
AstraZeneca Pharmaceuticals LP $84.8106/14/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104776054 CMS
AstraZeneca Pharmaceuticals LP $9.7406/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105279064 CMS
AstraZeneca Pharmaceuticals LP $38.7006/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105569417 CMS
AstraZeneca Pharmaceuticals LP $64.1206/13/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105632221 CMS
AstraZeneca Pharmaceuticals LP $58.8006/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105658354 CMS
AstraZeneca Pharmaceuticals LP $16.8106/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105815993 CMS
AstraZeneca Pharmaceuticals LP $19.8506/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105860370 CMS
AstraZeneca Pharmaceuticals LP $1,300.0006/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105414685 CMS
AstraZeneca Pharmaceuticals LP $11.8306/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104780470 CMS
AstraZeneca Pharmaceuticals LP $8.1806/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105732155 CMS
Regeneron Healthcare Solutions, Inc. $28.0006/11/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114130351 CMS
Regeneron Healthcare Solutions, Inc. $25.0006/11/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114130353 CMS
AstraZeneca Pharmaceuticals LP $3,250.0006/03/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105433981 CMS
Regeneron Healthcare Solutions, Inc. $3,758.0005/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114130349 CMS
AstraZeneca Pharmaceuticals LP $5,200.0005/28/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104755200 CMS
AstraZeneca Pharmaceuticals LP $650.0005/21/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105748357 CMS
Regeneron Healthcare Solutions, Inc. $10,438.0005/21/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114130347 CMS
AstraZeneca Pharmaceuticals LP $2,051.1405/20/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104583302 CMS
AstraZeneca Pharmaceuticals LP $318.9305/20/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105604661 CMS
AstraZeneca Pharmaceuticals LP $134.9805/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105848620 CMS
AstraZeneca Pharmaceuticals LP $104.7405/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104472096 CMS
AstraZeneca Pharmaceuticals LP $74.6005/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104754716 CMS
AstraZeneca Pharmaceuticals LP $135.0005/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105588468 CMS
Regeneron Healthcare Solutions, Inc. $187.8305/16/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114130343 CMS
Regeneron Healthcare Solutions, Inc. $187.8305/16/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114130345 CMS
AstraZeneca Pharmaceuticals LP $1,300.0005/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105755185 CMS
GENZYME CORPORATION $2,923.0005/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139635195 CMS
AstraZeneca Pharmaceuticals LP $5,200.0004/25/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105728593 CMS
AstraZeneca Pharmaceuticals LP $4,550.0004/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104709617 CMS
GENZYME CORPORATION $3,758.0004/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139635183 CMS
GENZYME CORPORATION $625.2004/24/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139635185 CMS
GENZYME CORPORATION $121.1304/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139635197 CMS
GENZYME CORPORATION $10,438.0004/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139635199 CMS
GENZYME CORPORATION $328.0204/23/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139635201 CMS
GENZYME CORPORATION $42.0004/23/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139635203 CMS
GENZYME CORPORATION $44.5704/23/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139635205 CMS
AstraZeneca Pharmaceuticals LP $23.0304/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105885295 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $141,916.86 113
PY2020 $68,489.91 36
PY2021 $52,975.01 36
PY2022 $89,588.70 87
PY2023 $145,906.35 126
PY2024 $204,116.87 137
PY2025 $307,001.27 206

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $133,996.32 9
PY2024 Principal investigator $307,818.46 9
PY2023 Principal investigator $436,044.63 21
PY2022 Principal investigator $239,385.21 4
PY2021 Recipient $750.00 2
PY2021 Principal investigator $65,571.00 2
PY2020 Recipient $1,246.66 2
PY2020 Principal investigator $158,146.32 4
PY2019 Principal investigator $168,787.74 6

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

9 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 GlaxoSmithKline, LLC. $33,443.70 11/20/2025 Non-covered Recipient Entity
RUTGERS THE STATE UNIVERSITY
THE COMBINATION OF UMECLIDINIUM AND VILANTEROL ENHANCES BRONCHODILATIO No dispute reported 06/30/2026 1192114748
Principal investigator 1 AstraZeneca Pharmaceuticals LP $11,910.00 10/22/2025 Non-covered Recipient Entity
RUTGERS THE STATE UNIVERSITY OF NEW JERSEY SCHOOL OF PUBLIC HEALTH
aumlticentre,randomised,open label,parallel group,phase IIIb study to assess the potential for tezepelumab treatedtie pants with severe asthma to reduce background therapy while sustaining asthma control and clinical remission No dispute reported 06/30/2026 1185537814
Principal investigator 1 PFIZER INC. $6,500.00 10/03/2025 Non-covered Recipient Entity
Rutgers The State University
A PHASE 2 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PARALLELGROUP DOSERANGING STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF PF07275315 IN ADULT PARTICIPANTS WITH INADEQUATELY CONTROLLED MODERATETOSEVERE ASTHMA No dispute reported 06/30/2026 1228729999
Principal investigator 1 GlaxoSmithKline, LLC. $2,340.00 08/13/2025 Non-covered Recipient Entity
RUTGERS THE STATE UNIVERSITY
A PROSPECTIVE, REAL-WORLD, INTERVENTIONAL STUDY TO EVALUATE THE EFFECT No dispute reported 06/30/2026 1192173771
Principal investigator 1 PFIZER INC. $17,261.00 07/16/2025 Non-covered Recipient Entity
Rutgers The State University
A PHASE 2 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PARALLELGROUP DOSERANGING STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF PF07275315 IN ADULT PARTICIPANTS WITH INADEQUATELY CONTROLLED MODERATETOSEVERE ASTHMA No dispute reported 06/30/2026 1228771612
Principal investigator 1 GlaxoSmithKline, LLC. $7,540.00 05/22/2025 Non-covered Recipient Entity
RUTGERS THE STATE UNIVERSITY
A PHASE 4, 52-WEEK (PRIMARY ANALYSIS AT 24-WEEKS), RANDOMIZED, STRATIF No dispute reported 06/30/2026 1192174713
Principal investigator 1 AstraZeneca Pharmaceuticals LP $11,744.32 04/28/2025 Non-covered Recipient Entity
RUTGERS THE STATE UNIVERSITY OF NEW JERSEY
The CHRONICLE Study is a multi center,non interventional,prospective cohort study of adults with severe asthma who do not achieve control with high-dose ICS therapy with additional controllers and or require systemic corticosteroid or monoclonal antibod No dispute reported 06/30/2026 1185537808
Principal investigator 1 AstraZeneca Pharmaceuticals LP $12,852.30 03/25/2025 Non-covered Recipient Entity
RUTGERS THE STATE UNIVERSITY OF NEW JERSEY SCHOOL OF PUBLIC HEALTH
ALTA - Albuterol budesonide Treatment in Acute airway obstruction his is a multi-center randomized double-blind 2-period cross-over study evaluating efficacy and safety of repeated doses of PT027 albuterol budesonide pressurized metered dose inhaler pMDI compared to PT007 albuterol pMDI in participants with asthma and acute airway obstruction induced by 2 mannitol challenges 7 hours apart No dispute reported 06/30/2026 1185537810
Principal investigator 1 AstraZeneca Pharmaceuticals LP $30,405.00 02/12/2025 Non-covered Recipient Entity
RUTGERS THE STATE UNIVERSITY OF NEW JERSEY
aumlticentre,randomised,open label,parallel group,phase IIIb study to assess the potential for tezepelumab treatedtie pants with severe asthma to reduce background therapy while sustaining asthma control and clinical remission No dispute reported 06/30/2026 1185537812